Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.34
-0.02 (-0.09%)
At close: Dec 5, 2025, 4:00 PM EST
21.52
+0.18 (0.84%)
After-hours: Dec 5, 2025, 7:30 PM EST
Avadel Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -0.28 | -48.83 | -160.28 | -137.46 | -77.33 | 7.03 | |
| Depreciation & Amortization | 3.68 | 2.68 | 1.77 | 1.49 | 0.82 | 1.69 | |
| Other Amortization | - | - | 2.8 | 6.05 | 1.25 | 6.52 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -45.76 | |
| Asset Writedown & Restructuring Costs | 20 | - | - | - | - | - | |
| Stock-Based Compensation | 18.56 | 20.39 | 15.81 | 7.01 | 8.87 | 3 | |
| Other Operating Activities | -0.82 | -0.83 | 14.39 | 28.07 | -14.61 | -6.89 | |
| Change in Accounts Receivable | -5.34 | -21.99 | -12.1 | - | - | 8.28 | |
| Change in Inventory | -8.01 | -9.22 | -9.53 | - | - | -1.35 | |
| Change in Accounts Payable | 4.49 | -4.09 | 1.55 | -3.11 | 4.23 | -2.79 | |
| Change in Other Net Operating Assets | 2.27 | 14.99 | 17.09 | 27.64 | -0.54 | -18.47 | |
| Operating Cash Flow | 34.54 | -46.91 | -128.51 | -70.3 | -77.31 | -48.73 | |
| Capital Expenditures | -0.19 | - | - | -0.72 | -0.03 | -0.1 | |
| Divestitures | - | - | - | - | 16.5 | 25.5 | |
| Sale (Purchase) of Intangibles | -15 | - | - | - | - | - | |
| Investment in Securities | 25.73 | 51.78 | -50.09 | 80.41 | 40.46 | -95.12 | |
| Investing Cash Flow | 10.54 | 51.78 | -50.09 | 79.7 | 56.93 | -69.72 | |
| Long-Term Debt Repaid | - | - | -38.67 | -8.65 | - | - | |
| Net Debt Issued (Repaid) | - | - | -38.67 | -8.65 | - | - | |
| Issuance of Common Stock | 5.06 | 15.97 | 148.36 | 28 | 0.26 | 179.68 | |
| Other Financing Activities | - | - | 25.64 | -4.8 | - | - | |
| Financing Cash Flow | 5.06 | 15.97 | 135.34 | 14.54 | 0.26 | 179.68 | |
| Foreign Exchange Rate Adjustments | 1.09 | -0.64 | 0.46 | -0.66 | -0.9 | 0.72 | |
| Net Cash Flow | 51.23 | 20.2 | -42.81 | 23.27 | -21.01 | 61.95 | |
| Free Cash Flow | 34.35 | -46.91 | -128.51 | -71.02 | -77.34 | -48.83 | |
| Free Cash Flow Margin | 13.82% | -27.74% | -459.57% | - | - | -218.64% | |
| Free Cash Flow Per Share | 0.35 | -0.49 | -1.60 | -1.18 | -1.32 | -0.89 | |
| Cash Interest Paid | 10.29 | 7.18 | 5.25 | 9.66 | 6.47 | 6.47 | |
| Cash Income Tax Paid | - | - | - | -29.06 | 0.08 | -1.7 | |
| Levered Free Cash Flow | 2.73 | -30.37 | -78.68 | -25.39 | -38.03 | -57.42 | |
| Unlevered Free Cash Flow | 8.8 | -23.6 | -75.3 | -23.73 | -33.07 | -55.83 | |
| Change in Working Capital | -6.59 | -20.32 | -3 | 24.54 | 3.7 | -14.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.